http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0752425-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8f02b50c134b461c7acbc8ca00d26d4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0817
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
filingDate 1996-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81126d70a5e8afb007e53575801f2f8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_043f60864bda2d437e0f777f57b8f014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f10ad03c1e528182346ae19b7fcf8d5
publicationDate 1997-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0752425-A3
titleOfInvention Peptide ligands for the constant region of immunoglobulins
abstract A peptide of formula (I) (H2N-X1-Thr-X2-CO)n-R where X1 and X2, different one another, are an amino acid residue of arginine or tyrosine in configuration L or D, wherein the hydroxy group of threonine and tyrosine and the guanidine moiety of arginine may be protected by a compound conventionally used in peptide chemistry for protecting the hydroxy group and the guanidine moiety, respectively, n is 1,2, 3 or 4, and R, when n is 2,3 or 4, is a group suitable for forming a dimer, trimer or tetramer, while, when n is 1, R is OH, a single amino acid residue, or a peptide chain comprising up to 7 amino acid residues.
priorityDate 1995-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9506125-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9318185-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128871932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127722163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1551643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129779609
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129266209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88555
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID138754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127469537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127944238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129815131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129510486

Total number of triples: 52.